28 related articles for article (PubMed ID: 15754039)
1. Transcriptional profiling of apoptosis: cell death classification moves toward the systems era.
Yao Z; Szabadkai G
Cell Cycle; 2012 Oct; 11(20):3721-2. PubMed ID: 22982998
[No Abstract] [Full Text] [Related]
2. p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress.
Cuenin S; Tinel A; Janssens S; Tschopp J
Oncogene; 2008 Jan; 27(3):387-96. PubMed ID: 17637755
[TBL] [Abstract][Full Text] [Related]
3. PIDD mediates NF-kappaB activation in response to DNA damage.
Janssens S; Tinel A; Lippens S; Tschopp J
Cell; 2005 Dec; 123(6):1079-92. PubMed ID: 16360037
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism.
Liang XJ; Finkel T; Shen DW; Yin JJ; Aszalos A; Gottesman MM
Mol Cancer Res; 2008 Sep; 6(9):1499-506. PubMed ID: 18723829
[TBL] [Abstract][Full Text] [Related]
5. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
6. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
7. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
Chang FL; Ling YF; Lai MD
Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
[TBL] [Abstract][Full Text] [Related]
8. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated and hypoacetylated mutant p53 enhances cisplatin-induced apoptosis through caspase-9 pathway in the absence of transcriptional activation or translation.
Lai MD; Lin WC; Sun YM; Chang FL
Int J Mol Med; 2005 Apr; 15(4):725-34. PubMed ID: 15754039
[TBL] [Abstract][Full Text] [Related]
11. p53-dependent apoptosis pathways.
Shen Y; White E
Adv Cancer Res; 2001; 82():55-84. PubMed ID: 11447765
[TBL] [Abstract][Full Text] [Related]
12. Regulation of translation initiation following stress.
Sheikh MS; Fornace AJ
Oncogene; 1999 Nov; 18(45):6121-8. PubMed ID: 10557103
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
